Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1236-1236
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Insulin and Insulin Resistance in Alzheimer’s Disease
Aleksandra Sędzikowska, Leszek Szablewski
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9987-9987
Open Access | Times Cited: 215
Phthalates Induce Neurotoxicity by Disrupting the Mfn2-PERK Axis-Mediated Endoplasmic Reticulum–Mitochondria Interaction
Yi Zhao, Yuan‐Hang Chang, Hao-Ran Ren, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 13, pp. 7411-7422
Closed Access | Times Cited: 25
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 2
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Paul Edison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 217-229
Open Access | Times Cited: 63
Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9540-9540
Open Access | Times Cited: 59
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 35
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review
Domenico Plantone, Matteo Pardini, Delia Righi, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 54-54
Open Access | Times Cited: 27
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways
Jingwen Wang, Jingyang Zhang, Zhi‐Ling Yu, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102416-102416
Closed Access | Times Cited: 11
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1257-1257
Open Access | Times Cited: 44
Mechanistic insight into the role of metformin in Alzheimer's disease
Mehdi Sanati, Samaneh Aminyavari, Amir R. Afshari, et al.
Life Sciences (2022) Vol. 291, pp. 120299-120299
Closed Access | Times Cited: 35
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21
GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes
M. Monney, François R. Jornayvaz, Karim Gariani
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101470-101470
Open Access | Times Cited: 20
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer’s Disease Model
Eunju Kim, Kazunari Nohara, Marvin Wirianto, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1004-1004
Open Access | Times Cited: 40
The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, et al.
Pharmacological Research (2021) Vol. 172, pp. 105805-105805
Closed Access | Times Cited: 33
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Saghar Rabiei Poor, Miren Ettcheto, Amanda Cano, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 890-890
Open Access | Times Cited: 33
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 15
Association of Alzheimer's dementia with oral bacteria, vitamin B12, folate, homocysteine levels, and insulin resistance along with its pathophysiology, genetics, imaging, and biomarkers
Priyadarshi Prajjwal, Shahnaz Asharaf, Dhruvi Makhanasa, et al.
Disease-a-Month (2023) Vol. 69, Iss. 5, pp. 101546-101546
Closed Access | Times Cited: 13
Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
Xiaolan Zhao, Zhanxue Cao, Ke-Di Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease
Feng-Qing Xu, Jingshan Shi
Journal of Alzheimer s Disease (2025)
Closed Access
Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia
Xin Ma, Xin-Meng Wang, Guozhang Tang, et al.
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
The Importance of Edible Medicinal Mushrooms and Their Potential Use as Therapeutic Agents Against Insulin Resistance
Zsuzsanna Németh, Mariann Paulinné Bukovics, Liza Dalma Sümegi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 827-827
Open Access
Page 1 - Next Page

Scroll to top